Apyx Medical (APYX) vs electroCore (ECOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
electroCore (ECOR) has outperformed Apyx Medical (APYX) over the past year, gaining 84.7% versus a loss of 17.8%. Over five years, ECOR leads with a -36.4% price change compared with -82.1% for APYX. Apyx Medical is the larger company by market cap ($105.9 million vs $87.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APYX | ECOR |
|---|---|---|
| Share price | $2.52 | $9.69 |
| Market cap | $105.94M | $87.36M |
| 1-day change | +6.57% | +1.89% |
| YTD return | -32.57% | +112.04% |
| 1-year return | -17.77% | +84.66% |
| 5-year return | -82.05% | -36.41% |
| EPS (TTM) | $-0.20 | $-1.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.08 | $12.70 |
| 52-week low | $2.32 | $4.41 |
| Distance from 52-week high | -50.49% | -23.70% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +158.45% | +97.83% |
| Average volume | 127.72K | 80.51K |
| Shares outstanding | 42.12M | 9.02M |
| Employees | 205 | 83 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ECOR has outperformed APYX by 102.4 percentage points over the past year.
About Apyx Medical
APYX stock →Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).
Health Care · Medical/Dental Instruments · 205 employees
About electroCore
ECOR stock →electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 83 employees
APYX vs ECOR FAQ
Which is bigger, Apyx Medical or electroCore?
Apyx Medical (APYX) is larger, with a market capitalization of $105.94M compared with $87.36M for electroCore (ECOR).
Which stock has performed better over the past year, APYX or ECOR?
ECOR returned +84.66% over the past 12 months, compared with -17.77% for APYX (price return, excluding dividends). Past performance does not predict future results.
Are Apyx Medical and electroCore in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Apyx Medical and Biotechnology: Electromedical & Electrotherapeutic Apparatus for electroCore.